OK
Oklahoma House Bill HB2686

Oklahoma 2023 Regular Session

Oklahoma House Bill HB2686 Compare Versions

OldNewDifferences
1-An Act
2-ENROLLED HOUSE
1+
2+
3+ENGR. S. A. TO ENGR. H. B. NO. 2686 Page 1 1
4+2
5+3
6+4
7+5
8+6
9+7
10+8
11+9
12+10
13+11
14+12
15+13
16+14
17+15
18+16
19+17
20+18
21+19
22+20
23+21
24+22
25+23
26+24
27+
28+ENGROSSED SENATE AMENDMENT
29+TO
30+ENGROSSED HOUSE
331 BILL NO. 2686 By: West (Rick) and Waldron of
432 the House
533
634 and
735
836 Burns of the Senate
937
1038
1139
1240
1341
14-An Act relating to substance abuse services; creating
15-the Hannah McKenzie Act of 2023; providing short
16-title; amending 43A O.S. 2021, Section 3 -601, which
17-relates to opioid substitution treatment programs;
18-requiring opioid substitution treatment programs to
19-comply with certain federal requirements; requiring
20-drug abuse testing to be directly observed;
42+An Act relating to mental health; amending 43A O.S.
43+2021, Section 3-601, which relates to opioid
44+substitution treatment programs and addicted
45+persons; mandating drug screens; and providing an
46+effective date.
47+
48+
49+
50+
51+
52+AMENDMENT NO. 1. Page 1, strike the title, enacting clause and
53+entire bill and insert
54+
55+
56+“An Act relating to substance abuse services;
57+creating the Hannah McKenzie Act of 2023; providing
58+short title; amending 43A O.S. 2021, Section 3 -601,
59+which relates to opioid substitution treatment
60+programs; requiring opioid substitution treatment
61+programs to comply with certa in federal requirements;
62+requiring drug abuse testing to be directly observed;
2163 broadening grounds for certain penalties; amending 59
2264 O.S. 2021, Section 478.1, which relates to
2365 establishment of physician -patient relationship
2466 through telemedicine; adding exc eption to certain
2567 restriction; providing for noncodifi cation; and
2668 declaring an emergency.
2769
2870
2971
72+BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
3073
31-SUBJECT: Substance abuse services
32-
33-BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
74+ENGR. S. A. TO ENGR. H. B. NO. 2686 Page 2 1
75+2
76+3
77+4
78+5
79+6
80+7
81+8
82+9
83+10
84+11
85+12
86+13
87+14
88+15
89+16
90+17
91+18
92+19
93+20
94+21
95+22
96+23
97+24
3498
3599 SECTION 1. NEW LAW A new section of law not to be
36100 codified in the Oklahoma Statutes reads as follows:
37-
38101 This act shall be known and may be ci ted as the “Hannah McKenzie
39102 Act of 2023”.
40-
41103 SECTION 2. AMENDATORY 43 A O.S. 2021, Section 3-601, is
42104 amended to read as follows:
43-
44105 Section 3-601. A. Any Class II controlled dangerous subs tance,
45-when used in this state by an opioid sub stitution treatment program ENR. H. B. NO. 2686 Page 2
106+when used in this state by an opioid sub stitution treatment program
46107 for persons with a history of opioid addiction to or physiologic
47108 dependence on controlled dangerous substances, shall only be u sed:
48-
49109 1. In treating persons with a history of addicti on;
50-
51110 2. In treating persons with a one-year history of opioid
52111 addiction to or physiolog ic dependence on control led dangerous
53112 substances, as defined by the Code of Federal Regulations, and
54113 documentation of attempting another type of treatment; or
55-
56114 3. If clinically appropriate, the program physician may waive
57115 the requirement of a one -year history of opioid addiction for
58116 consumers within six (6) months of release from a penal institution,
59117 for consumers with a pregnancy verified by the program physician, or
60118 for consumers having previously received treatment for opioid
61119 addiction and within two (2) years of discharge from that treatment
62120 episode.
63121
122+ENGR. S. A. TO ENGR. H. B. NO. 2686 Page 3 1
123+2
124+3
125+4
126+5
127+6
128+7
129+8
130+9
131+10
132+11
133+12
134+13
135+14
136+15
137+16
138+17
139+18
140+19
141+20
142+21
143+22
144+23
145+24
146+
64147 B. Any conviction for a violation of the provis ions of this
65148 section or any rules promulgated pursuant to the provisions of this
66149 section shall be a felony.
67-
68150 C. For the purposes of this section, “opioid substitution
69151 treatment program” means a person, private physician , or
70152 organization that administers or dispenses an opioid drug to a
71153 narcotic addict for the purposes of detoxification or maintenance
72154 treatment or provides, when necessary and appropriate, comprehensive
73155 medical and rehabilitation services. A private physi cian who
74156 administers buprenorphine wi th a waiver from the Drug Enforcement
75157 Administration shall not be considered an opioid substitution
76158 treatment program.
77-
78159 D. An opioid substitution treatment program shall be certified
79160 by the Board of Mental Health and Subst ance Abuse Services, or the
80161 Commissioner of Mental Health and Substance Abuse Services upon
81162 delegation by the Board, and registered with the federal Drug
82163 Enforcement Administration for the use of an opioid drug to treat
83164 narcotic addiction.
84-
85165 D. E. The Board of Mental Health and Substance Abuse Se rvices
86166 shall promulgate rules and standards for the certification of all
87167 programs, private facilities, and organi zations which provide opioid
88168 substitution treatment directed to those physiologically dependent
89169 on or addicted to opioids. These facilities an d organizations shall
90-be known as “Opioid Substitution Treatment Programs”. Only ENR. H. B. NO. 2686 Page 3
170+be known as “Opioid Substitution Treatment Programs”. Only
171+
172+ENGR. S. A. TO ENGR. H. B. NO. 2686 Page 4 1
173+2
174+3
175+4
176+5
177+6
178+7
179+8
180+9
181+10
182+11
183+12
184+13
185+14
186+15
187+16
188+17
189+18
190+19
191+20
192+21
193+22
194+23
195+24
196+
91197 certified facilities may receiv e and assist opioid-dependent and
92198 addicted persons by providing Class II controlled substances in
93199 opioid substitution treatment and rehabilitat ion.
94-
95200 E. F. The Board of Mental Health and Substance Abuse Services
96201 shall promulgate rules and standards regulati ng the treatment and
97202 services provided by opioid substitution treatment p rograms.
98203 Failure to comply with rul es and standards promulgated by the B oard
99204 shall be grounds for revocation, suspension or nonrenewal of
100205 certification.
101-
102206 F. G. An opioid substitution treatment program shall comply
103207 with all federal requirements for opioid treatment programs provided
104208 by 42 C.F.R., Subpart C including but not limited to t he requirement
105209 to provide drug abuse testing services provided by 42 C.F.R.,
106210 Section 8.12(f)(6). Drug abuse testing shall be dire ctly observed
107211 by an employee or contractor of the opioid substitution treatment
108212 program.
109-
110213 H. Opioid substitution treatment pro grams shall notify the
111214 Department of Mental Health and Substance Abuse Services of plans to
112215 close or relocate within a minimum of thirty ( 30) days prior to
113216 closure or relocation.
114-
115217 G. I. Failure to comply with rules and standards promulgated by
116218 the Board of Mental Health and Substance Abuse Services pursuant to
117219 this section or failure to comply with the requirements of 42
220+
221+ENGR. S. A. TO ENGR. H. B. NO. 2686 Page 5 1
222+2
223+3
224+4
225+5
226+6
227+7
228+8
229+9
230+10
231+11
232+12
233+13
234+14
235+15
236+16
237+17
238+18
239+19
240+20
241+21
242+22
243+23
244+24
245+
118246 C.F.R., Subpart C shall be grounds for reprimand, suspension,
119247 revocation or nonrenewal of certification.
120-
121248 SECTION 3. AMENDATORY 59 O.S. 2021, Section 478.1, is
122249 amended to read as fol lows:
123-
124-Section 478.1 A. Unless otherwise prohibited by law, a valid
250+Section 478.1. A. Unless otherwise prohibited by law, a valid
125251 physician-patient relationship may be established by an allopathic
126252 or osteopathic physician with a patient located in this state
127253 through telemedicine, provided that the physician:
128-
129254 1. Holds a license to practice medicine in this state;
130-
131255 2. Confirms with the patient the patient 's identity and
132256 physical location; and
133-
134257 3. Provides the patient with the treating physician 's identity
135-and professional credentials. ENR. H. B. NO. 2686 Page 4
136-
258+and professional credentials.
137259 B. Telemedicine encounters shal l comply with the Health
138260 Insurance Portability and Accountability Act of 1996 and ensure that
139261 all patient communications and records are secure and confidential.
140-
141262 C. Telemedicine encounte rs in this state shall not be used to
142263 establish a valid physician -patient relationship for the purpose of
143264 prescribing opiates, synthetic opiates, semisynthetic opiates,
144265 benzodiazepine or carisprodol, but may be unless the encounter is
145266 used to prescribe opioid:
146-
147267 1. Opioid antagonists or partial agonists pursuant to Sections
148268 1-2506.1 and 1-2506.2 of Title 63 of the Oklahoma Statutes ; or
269+
270+ENGR. S. A. TO ENGR. H. B. NO. 2686 Page 6 1
271+2
272+3
273+4
274+5
275+6
276+7
277+8
278+9
279+10
280+11
281+12
282+13
283+14
284+15
285+16
286+17
287+18
288+19
289+20
290+21
291+22
292+23
293+24
149294
150295 2. A Schedule III, IV, or V controlled dangerous substance
151296 approved by the United States F ood and Drug Administration for
152297 medication assisted treatment or detoxification treatment for
153298 substance use disorder.
154-
155299 D. A physician-patient relationship shall not be created solely
156300 based on the receipt of patient health information by a physician.
157301 The duties and obligations created by a physician-patient
158302 relationship shall not apply until the physician affirmatively:
159-
160303 1. Undertakes to diagnose and treat the patient; or
161-
162304 2. Participates in the diagnosis and treatment of the patient.
163-
164305 SECTION 4. It being immediately necessary for the preservation
165306 of the public peace, health or safety, an em ergency is hereby
166307 declared to exist, by reason whereof this act shall take effect and
167-be in full force from and after its passage and approval.
168- ENR. H. B. NO. 2686 Page 5
308+be in full force from and after its passage and approval. ”
309+Passed the Senate the 26th day of April, 2023.
169310
170-Passed the House of Repre sentatives the 10th day of May, 2023.
311+
312+
313+ Presiding Officer of the Senate
314+
315+
316+Passed the House of Repre sentatives the ____ day of _______ ___,
317+2023.
318+
319+
320+
321+ Presiding Officer of the House
322+ of Representatives
323+
324+ENGR. H. B. NO. 2686 Page 1 1
325+2
326+3
327+4
328+5
329+6
330+7
331+8
332+9
333+10
334+11
335+12
336+13
337+14
338+15
339+16
340+17
341+18
342+19
343+20
344+21
345+22
346+23
347+24
348+
349+ENGROSSED HOUSE
350+BILL NO. 2686 By: West (Rick) and Waldron of
351+the House
352+
353+ and
354+
355+ Burns of the Senate
356+
357+
358+
359+
360+
361+An Act relating to mental health; amending 43A O.S.
362+2021, Section 3-601, which relates to opioid
363+substitution treatment programs and addicted
364+persons; mandating drug screens; and providing an
365+effective date.
366+
367+
368+
369+
370+
371+BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLA HOMA:
372+SECTION 5. AMENDATORY 43 A O.S. 2021, Section 3-601, is
373+amended to read as follows:
374+Section 3-601. A. Any Class II controlled dangerous substance,
375+when used in this state by an opioid substitution treatment program
376+for persons with a history of opioid addiction to or physiologic
377+dependence on controlled dangerous substances, shall only be used:
378+1. In treating persons with a history of addiction ;
379+2. In treating persons with a one -year history of opioid
380+addiction to or physiolog ic dependence on control led dangerous
381+substances, as defined by the Code of Federal Regulations, and
382+documentation of attem pting another type of treatment; or
383+
384+ENGR. H. B. NO. 2686 Page 2 1
385+2
386+3
387+4
388+5
389+6
390+7
391+8
392+9
393+10
394+11
395+12
396+13
397+14
398+15
399+16
400+17
401+18
402+19
403+20
404+21
405+22
406+23
407+24
408+
409+3. If clinically appro priate, the program physician may waive
410+the requirement of a one -year history of opioid addiction for
411+consumers within six (6) months of release from a penal institution,
412+for consumers with a pregn ancy verified by the program physician, or
413+for consumers having previously received treatment for opioid
414+addiction and within two (2) years of discharge from that treatment
415+episode.
416+Provided, however, that persons who are participating in the
417+opioid substitution treatment program, pursuant to this subsection,
418+shall be administered a minimum of eight random, witnessed, urine
419+drug screens annually.
420+B. Any conviction for a violation of the provis ions of this
421+section or any rules promulgated pursuant to th e provisions of this
422+section shall be a felony.
423+C. For the purposes of this section, "opioid substitution
424+treatment program" means a person, private physician , or
425+organization that administers or dispenses an opioid drug to a
426+narcotic addict for the purpo ses of detoxification or maintenance
427+treatment or provides, when necessary and appropriate, comprehensive
428+medical and rehabilitation services. A private physi cian who
429+administers buprenorphine wi th a waiver from the Drug Enforcement
430+Administration shall n ot be considered an opioid substitution
431+treatment program. An opioid substitution treatment program shall
432+be certified by the Board of Mental Health and Subst ance Abuse
433+
434+ENGR. H. B. NO. 2686 Page 3 1
435+2
436+3
437+4
438+5
439+6
440+7
441+8
442+9
443+10
444+11
445+12
446+13
447+14
448+15
449+16
450+17
451+18
452+19
453+20
454+21
455+22
456+23
457+24
458+
459+Services, or the Commissio ner of Mental Health and Substance Abuse
460+Services upon delegation by the Board, and registered with the
461+federal Drug Enforcement Administration for the use of an opioid
462+drug to treat narcotic addiction.
463+D. The Board of Mental Health and Substance Abuse Se rvices
464+shall promulgate rules and standards for the certific ation of all
465+programs, private facilities, and organization s which provide opioid
466+substitution treatment directed to those physiologically dependent
467+on or addicted to opioids. These facilities an d organizations shall
468+be known as "Opioid Substitution Treat ment Programs". Only
469+certified facilities may receive and assist opioid-dependent and
470+addicted persons by providing Class II controlled substances in
471+opioid substitution treatment and rehabilitat ion.
472+E. The Board of Mental Health and Substance Abuse Serv ices
473+shall promulgate rules and standards regulating the tr eatment and
474+services provided by opioid substitution treatment p rograms.
475+Failure to comply with rul es and standards promulgated by the B oard
476+shall be grounds for revocation, suspension or nonrenew al of
477+certification.
478+F. Opioid substitution treatment prog rams shall notify the
479+Department of Mental Health and Substance Abuse Services of plans to
480+close or relocate within a minimum of thirty ( 30) days prior to
481+closure or relocation.
482+
483+ENGR. H. B. NO. 2686 Page 4 1
484+2
485+3
486+4
487+5
488+6
489+7
490+8
491+9
492+10
493+11
494+12
495+13
496+14
497+15
498+16
499+17
500+18
501+19
502+20
503+21
504+22
505+23
506+24
507+
508+G. Failure to comply with rules and standards promulgated by
509+the Board of Mental Health and Substance Abuse Services pursuant to
510+this section shall be grounds for reprimand, sus pension, revocation
511+or nonrenewal of certification.
512+SECTION 6. This act shall be come effective November 1, 2023.
513+Passed the House of Representatives the 23rd day of March, 2023.
514+
171515
172516
173517
174518 Presiding Officer of the House
175519 of Representatives
176520
177521
522+Passed the Senate the ____ day of __________, 2023.
178523
179-Passed the Senate the 26th day of April, 2023.
180524
181525
182526
183527 Presiding Officer of the Senate
184528
185529
186530
187-OFFICE OF THE GOVERNOR
188-Received by the Office of the Governor this ____________________
189-day of ___________________, 20_______, at _______ o'clock _______ M.
190-By: _________________________________
191-Approved by the Governor of the State of Oklahoma this _____ ____
192-day of ___________________, 20_______, at _______ o'clock _______ M.
193-
194-
195- _________________________________
196- Governor of the State of Oklahoma
197-
198-OFFICE OF THE SECRETARY OF STATE
199-Received by the Offic e of the Secretary of State this __________
200-day of ___________________, 20_______, at _______ o'clock _______ M.
201-By: _________________________________